Audit 307789

FY End
2023-08-31
Total Expended
$8.10M
Findings
16
Programs
7
Year: 2023 Accepted: 2024-05-31

Organization Exclusion Status:

Checking exclusion status...

Findings

ID Ref Severity Repeat Requirement
399261 2023-002 Significant Deficiency Yes L
399262 2023-003 Material Weakness - I
399263 2023-002 Significant Deficiency Yes L
399264 2023-003 Material Weakness - I
399265 2023-002 Significant Deficiency Yes L
399266 2023-003 Material Weakness - I
399267 2023-002 Significant Deficiency Yes L
399268 2023-003 Material Weakness - I
975703 2023-002 Significant Deficiency Yes L
975704 2023-003 Material Weakness - I
975705 2023-002 Significant Deficiency Yes L
975706 2023-003 Material Weakness - I
975707 2023-002 Significant Deficiency Yes L
975708 2023-003 Material Weakness - I
975709 2023-002 Significant Deficiency Yes L
975710 2023-003 Material Weakness - I

Contacts

Name Title Type
LBNNLRDE8793 Andre Stringfellow Auditee
4024513553 Taylor Kendall Auditor
No contacts on file

Notes to SEFA

Title: BASIS OF PRESENTATION Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal award activity of Charles Drew Health Center, Inc. under programs of the federal government for the year ended August 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Charles Drew Health Center, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Charles Drew Health Center, Inc.Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass‐through entity identifying numbers are presented where available. De Minimis Rate Used: Y Rate Explanation: Charles Drew Health Center, Inc. has elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal award activity of Charles Drew Health Center, Inc. under programs of the federal government for the year ended August 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Charles Drew Health Center, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Charles Drew Health Center, Inc.
Title: SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal award activity of Charles Drew Health Center, Inc. under programs of the federal government for the year ended August 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Charles Drew Health Center, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Charles Drew Health Center, Inc.Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass‐through entity identifying numbers are presented where available. De Minimis Rate Used: Y Rate Explanation: Charles Drew Health Center, Inc. has elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass‐through entity identifying numbers are presented where available.
Title: INDIRECT COST RATE Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal award activity of Charles Drew Health Center, Inc. under programs of the federal government for the year ended August 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Charles Drew Health Center, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Charles Drew Health Center, Inc.Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass‐through entity identifying numbers are presented where available. De Minimis Rate Used: Y Rate Explanation: Charles Drew Health Center, Inc. has elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. Charles Drew Health Center, Inc. has elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance.
Title: CONTINGENCIES Accounting Policies: The accompanying Schedule of Expenditures of Federal Awards (the "Schedule") includes the federal award activity of Charles Drew Health Center, Inc. under programs of the federal government for the year ended August 31, 2023. The information in this Schedule is presented in accordance with the requirements of Title 2 U.S. Code of Federal Regulations Part 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards (Uniform Guidance). Because the Schedule presents only a selected portion of the operations of Charles Drew Health Center, Inc., it is not intended to and does not present the financial position, changes in net assets or cash flows of Charles Drew Health Center, Inc.Expenditures reported on the Schedule are reported on the accrual basis of accounting. Such expenditures are recognized following the cost principles contained in the Uniform Guidance, wherein certain types of expenditures are not allowable or are limited as to reimbursement. Pass‐through entity identifying numbers are presented where available. De Minimis Rate Used: Y Rate Explanation: Charles Drew Health Center, Inc. has elected to use the 10% de minimis indirect cost rate allowed under the Uniform Guidance. Charles Drew Health Center, Inc. receives funds under various federal grant programs, and such assistance is to be expended in accordance with the provisions of the various grants. Compliance with the grants is subject to audit by various government agencies which may impose sanctions in the event of noncompliance. Management believes that they have complied with all material aspects of the various grant provisions and the results of adjustments, if any, relating to such audits would not have any material financial impacts.

Finding Details

Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.
Noncompliance and Significant Deficiency in Internal Control over Compliance for Reporting Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to submit federal financial reports (SF‐425), the UDS Report, and Budget Progress Reports (BPR) in accordance with established requirements and deadlines. Condition: Two of five reports reviewed were not submitted timely. The SF‐425 report for Award No. H80CS00438 was due on 4/30/23 and was submitted on 6/15/23. The SF‐425 report for Award No. H8FCS40427 was due on 4/30/23 and was submitted on 7/31/2023. Cause: During the year, there was turnover in the accounting department. Effect: Late submission of reports could result in a delay in future federal funding drawdowns. Questioned costs: n/a Context: Five reports submitted during the year were selected for testing. Repeat Finding: 2022‐001 Recommendation: The Organization should review and evaluate grant reporting deadlines for their federal awards and update internal control procedures for reporting. Views of Responsible Officials: Management agrees with this finding. Management has contracted with an outside vendor/ CPA firm to assist in the regular tracking and reporting of grant‐related expenditures. Also, the Organization is in the process of creating the administrative infrastructure which includes new staff, new workflow and processes that are designed to report grant activity monthly which includes the timely submission of all grant related reports
Noncompliance and Material Weakness in Internal Control for Procurement, Suspension and Debarment Health Center Program Cluster CFDA No. 93.224 and 93.527 U.S. Department of Health and Human Services Award No. H80CS00438 and H8FCS40427 Criteria: The Organization is required to create a written procurement, suspension and debarment policy that complies with applicable federal requirements as indicated in 2 CFR 200.318 ‐200.326 and to follow this policy when procuring goods and services. Condition: During the testing performed, it was determined that documentation to support quotes, estimates, or closed bids were not maintained prior to entering into contracts. Additionally, documentation was not maintained to support that the vendors were not suspended or debarred. Cause: The Organization has designed internal controls over these areas; however, the controls did not operate as designed. Effect: Purchases were made that did not adhere to the Health Organization’s procurement, suspension and debarment policy. Questioned costs: n/a Context: The Organization did not maintain supporting documentation that management obtained price or rate quotes for purchases above the micro‐purchase threshold. In addition, the Health Center did not maintain documentation to support that the vendors were not suspended or debarred, however subsequent testing verified that none of the vendors selected for review were suspended or debarred. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation. Repeat Finding: n/a Recommendation: The Organization should review and update the procurement and suspension and debarment policies. Additionally, the Organization should provide training to staff on transactions that are covered by the procurement, suspension and debarment policies. Views of Responsible Officials: Management agrees with this finding. Procedures will be developed and staff will be trained to ensure future procurement, suspension and debarment transactions are identified and documentation is maintained to support the evaluation.